International Clinical Trial: Study on the Mechanism of TRAF6 in Regulating IL-4/STAT6 Signaling Pathway Activation in Macrophage M2 Polarization and Atherosclerosis

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115100) titled 'Study on the Mechanism of TRAF6 in Regulating IL-4/STAT6 Signaling Pathway Activation in Macrophage M2 Polarization and Atherosclerosis' on Dec. 22, 2025.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Huzhou Center Hospital

Condition: Atherosclerosis

Intervention: AS group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: AS group:20;Healthy group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=298085

Published by HT Digital Content Services with perm...